TBPH vs TM · P/E 7.5, rev $18.8M vs P/E 9.7, rev $234.60B
Theravance Biopharma Inc (TBPH) versus Toyota Motor Corporation ADR (TM) — a side-by-side from cached financials, not a winner call.
Theravance Biopharma Inc (TBPH) is a biotechnology company listed on NASDAQ.
Toyota Motor Corporation ADR (TM) is a auto manufacturers company listed on NYSE.
Latest reported TBPH revenue for 2024-12-31 was $18.8M. Net income was -$15.5M. Revenue was up 11.2% from 2024-09-30 to 2024-12-31. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
Latest reported TM revenue for 2013-03-31 was $234.60B. Net income was $10.23B. Revenue was up 3.8% from 2012-03-31 to 2013-03-31. TM currently screens at market cap $211.00B and trailing P/E 9.7.
TBPH currently screens at market cap $861.5M and trailing P/E 7.5. TM currently screens at market cap $211.00B and trailing P/E 9.7.
Not investment advice. Open the TBPH and TM stock pages for the full models.
Not investment advice.